- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04726813
An Internet-delivered Intervention for Coping With ADHD in Adulthood (MyADHD)
June 14, 2022 updated by: Robin Maria Francisca Kenter, University of Bergen
An Internet-delivered Intervention for Coping With ADHD in Adulthood - a Randomized Controlled Trial
The primary aim of this study is to examine the efficacy of a self-guided Internet-delivered intervention for coping with ADHD.
The secondary aim is to investigate the effects of individual adaptation of the intervention on adherence, satisfaction and clinical outcomes.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
ADHD in adulthood, with an estimated prevalence of 2 - 3 %, is associated with challenges in daily life functioning.
The availability of evidence-based psychological interventions for adults with ADHD is poor.
Interventions delivered over the Internet might help to increase the availability of effective psychological interventions for this group.
The primary aim of this study is to examine the efficacy of a self-guided Internet-delivered intervention for coping with ADHD.
The secondary aim is to investigate the effects of individual adaptation of the intervention on adherence, satisfaction and clinical outcomes.
A minimum of 118 participants with a self-reported ADHD diagnosis will be included in the study.
In phase 1 we will conduct a randomized controlled trial with two arms, 1) self-guided Internet-delivered intervention for coping with ADHD (N=59), 2) self-guided online psychoeducation (control group, N= 59), with a 3 month follow-up.
After 3 months the second phase of the study starts.
In this phase (II) the control group participants will receive an adaptive version of the Internet-delivered intervention.
This includes adaptation of the order of the modules to the individual participant needs, with the use of rule-based and machine-learning based adaptation.
Clinical outcomes in both phases are inattention, hyperactivity, quality of life and stress.
Uptake, usage, adherence and satisfaction will be explored.
Repeated measurers are at baseline, weekly during the intervention period, post-intervention and 3 months follow-up.
Study Type
Interventional
Enrollment (Actual)
120
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Vestland
-
Bergen, Vestland, Norway
- Clinical Psychology
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Adults with a self-reported diagnosis of ADHD (date, venue and diagnosing physician)
- Access to and ability to use a computer, smartphone and the Internet.
- Current problems with organizing daily activity and 17 points of more on at least one of the ASRS subscales
- Participant are by investigators considered able to follow through the training protocol and take part in measures taken during the study time frame
Speaks, writes and reads Norwegian
Exclusion Criteria:
- Current self-reported diagnosis of severe psychiatric illness such as borderline or antisocial personality disorder, bipolar disorder, ongoing substance abuse, and/or suicidal ideation assessed with item 9 on the MADRS
- Participants who are taking prescribed ADHD medication have to be stable on the medication at least four weeks before the study and during the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: a self-guided Internet delivered intervention
MinADHD: 7 self-help modules.
|
The main goals of the intervention are to help participants with better functioning in daily life; offer strategies that will lead to stress reduction and reduce inattention and improve quality of life.The intervention includes: a short introductory chapter (open to everyone), followed by a start module (goal setting), followed by 6 different themed optional modules.
Module content is based on GMT, DBT and CBT techniques and is tailored towards key concerns and difficulties experienced adults with ADHD as informed by previous research (focus-groups, lived experience groups) and experiences from group GMT and DBT.
|
Placebo Comparator: Psycho-education
One self-guided psychoeducation module
|
Participants in the control condition will be assigned to psychoeducation modules (see Table 2) and will receive restricted access to the platform.
They can contact or be contacted if their symptoms levels increases.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The Adult ADHD Self-Rating Scale (ASRS)
Time Frame: Change in ADHD symptoms at 8 weeks
|
The Adult ADHD Self-Rating Scale (ASRS) includes all the 18 symptoms of ADHD included in the diagnostic manual (DSM-5).
|
Change in ADHD symptoms at 8 weeks
|
Adult ADHD Quality of Life Measure (AAQol)
Time Frame: Change in quality of life at 8 weeks
|
The AAQoL has 29 items designed to assess HRQL during the past two weeks among adults with ADHD.
|
Change in quality of life at 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The perceived stress scale (PSS)
Time Frame: Change in stress symptoms at 8 weeks
|
The Perceived Stress Scale (PSS) is a widely used psychological instrument for measuring stress.
|
Change in stress symptoms at 8 weeks
|
The Patient Health Questionnaire-9 (PHQ-9)
Time Frame: Change in depression symptoms at 8 weeks
|
The Patient Health Questionnaire-9 (PHQ-9: Kroenke et al., 2001) is a self-report tool used to assess the presence and severity of depressive symptoms
|
Change in depression symptoms at 8 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Adherence
Time Frame: immediately after the intervention
|
Usage outcomes of interest are attrition and adherence to the intervention.
|
immediately after the intervention
|
User satisfaction
Time Frame: immediately after the intervention
|
Four open end questions at the end of the modules:
|
immediately after the intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 27, 2021
Primary Completion (Actual)
October 20, 2021
Study Completion (Actual)
December 20, 2021
Study Registration Dates
First Submitted
January 8, 2021
First Submitted That Met QC Criteria
January 25, 2021
First Posted (Actual)
January 27, 2021
Study Record Updates
Last Update Posted (Actual)
June 15, 2022
Last Update Submitted That Met QC Criteria
June 14, 2022
Last Verified
June 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- 203804
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on ADHD
-
Stéphanie BaggioUniversity Hospital, Geneva; Leiden University; University of Bern; School of Health...Not yet recruiting
-
Okinawa Institute of Science and Technology Graduate...Japan society for the promotion of science; Miyazaki International CollegeRecruiting
-
King's College LondonSouth London and Maudsley NHS Foundation TrustNot yet recruiting
-
Universidad de GranadaNot yet recruiting
-
Izmir Katip Celebi UniversityDokuz Eylul UniversityNot yet recruiting
-
Seattle Children's HospitalNational Institute of Mental Health (NIMH); University of WashingtonRecruiting
-
University of California, DavisRecruiting
-
Chen LiRecruiting
-
Region SyddanmarkRecruiting